GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » Cyclically Adjusted PS Ratio

Universal Vision Biotechnology Co (ROCO:3218) Cyclically Adjusted PS Ratio : 9.53 (As of Jun. 21, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co Cyclically Adjusted PS Ratio?

As of today (2024-06-21), Universal Vision Biotechnology Co's current share price is NT$249.00. Universal Vision Biotechnology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was NT$26.14. Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio for today is 9.53.

The historical rank and industry rank for Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:3218' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.21   Med: 13.41   Max: 19.43
Current: 9.56

During the past years, Universal Vision Biotechnology Co's highest Cyclically Adjusted PS Ratio was 19.43. The lowest was 3.21. And the median was 13.41.

ROCO:3218's Cyclically Adjusted PS Ratio is ranked worse than
86.22% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs ROCO:3218: 9.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Universal Vision Biotechnology Co's adjusted revenue per share data for the three months ended in Dec. 2023 was NT$11.676. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$26.14 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Universal Vision Biotechnology Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co Cyclically Adjusted PS Ratio Chart

Universal Vision Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.10 13.63 14.02 12.72 10.60

Universal Vision Biotechnology Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.72 15.97 16.36 13.18 10.60

Competitive Comparison of Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio falls into.



Universal Vision Biotechnology Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=249.00/26.14
=9.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Vision Biotechnology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Universal Vision Biotechnology Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=11.676/129.4194*129.4194
=11.676

Current CPI (Dec. 2023) = 129.4194.

Universal Vision Biotechnology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 3.165 99.695 4.109
201406 3.225 100.560 4.151
201409 3.403 100.428 4.385
201412 3.282 99.070 4.287
201503 3.317 99.621 4.309
201506 3.370 100.684 4.332
201509 3.451 100.392 4.449
201512 3.260 99.792 4.228
201603 3.310 100.470 4.264
201606 3.728 101.688 4.745
201609 3.716 101.861 4.721
201612 3.791 101.863 4.817
201703 3.370 102.862 4.240
201706 3.323 103.349 4.161
201709 3.391 104.136 4.214
201712 3.276 104.011 4.076
201803 3.219 105.290 3.957
201806 3.607 106.317 4.391
201809 3.615 106.507 4.393
201812 3.610 105.998 4.408
201903 3.658 107.251 4.414
201906 4.221 108.070 5.055
201909 4.292 108.329 5.128
201912 4.553 108.420 5.435
202003 4.647 108.902 5.523
202006 5.710 108.767 6.794
202009 7.059 109.815 8.319
202012 6.765 109.897 7.967
202103 7.196 111.754 8.333
202106 7.235 114.631 8.168
202109 7.897 115.734 8.831
202112 8.680 117.630 9.550
202203 9.848 121.301 10.507
202206 9.315 125.017 9.643
202209 10.733 125.227 11.092
202212 11.278 125.222 11.656
202303 12.121 127.348 12.318
202306 11.796 128.729 11.859
202309 12.522 129.860 12.480
202312 11.676 129.419 11.676

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Universal Vision Biotechnology Co  (ROCO:3218) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Universal Vision Biotechnology Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Vision Biotechnology Co (ROCO:3218) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115
Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines